Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of the Efficacy of Saccharomyces Boulardii and Rifaximin in the Treatment of Abdominal Distension and Diarrhea Related to Small Intestinal Bacterial Overgrowth：a Non-inferiority Randomized Controlled Study

NCT07815548 is registered in ClinicalTrials.gov with Shandong University as lead sponsor.

NCT NCT07815548
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07815548 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of the Efficacy of Saccharomyces Boulardii and Rifaximin in the Treatment of Abdominal Distension and Diarrhea Related to Small Intestinal Bacterial Overgrowth：a Non-inferiority Randomized Controlled Study
Lead sponsor
Shandong University
Phase
Phase 4
Overall status
Not yet recruiting
Start date
September 10, 2026
Completion date
December 31, 2027
Enrollment
222 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

small intestinal bacterial overgrowth syndrome (sibo)